Skip to main content
Year archive

Alphamab Oncology — 2021 filings

All 48 regulatory filings released by Alphamab Oncology (9966) in 2021, sourced directly from the official regulator.

48 Filings
2021 Period
2021 filings (48)
Filing Released Lang
Next Day Disclosure Return
Regulatory Filings
2021-12-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings
2021-12-03 English
Next Day Disclosure Return
Regulatory Filings
2021-11-26 English
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
Regulatory Filings
2021-11-25 English
VOLUNTARY ANNOUNCEMENT - KN035 (ENVAFOLIMAB) OBTAINED MARKETING APPROVAL IN CHINA FROM NMPA
Regulatory Filings
2021-11-25 English
VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY NMPA FOR A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED PDAC
Regulatory Filings
2021-11-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Regulatory Filings
2021-11-04 English
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF COMMERCIAL OFFICER
Regulatory Filings
2021-11-02 English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE II/III CLINICAL TRIAL OF KN046 IN COMBINATION WITH LENVATINIB FOR THE TREATMENT OF PD-(L)1 REFRACTORY ADVANCED NSCLC
Regulatory Filings
2021-10-28 English
GRANT OF SHARE OPTIONS
Regulatory Filings
2021-10-25 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF PATIENT ENROLLMENT IN A PHASE III CLINICAL TRIAL OF KN046 IN COMBINATION WITH CHEMOTHERAPY IN THE TREATMENT OF ADVANCED UNRESECTABLE OR METASTATIC SQUAMOUS NSCLC
Regulatory Filings
2021-10-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Regulatory Filings
2021-10-08 English
2021 INTERIM REPORT
Regulatory Filings
2021-09-27 English
VOLUNTARY ANNOUNCEMENT - UPDATES ON CLINICAL DATA FROM PHASE II CLINICAL STUDY OF KN046 COMBINED WITH CHEMOTHERAPY IN THE FIRST-LINE TREATMENT OF PDAC FOR PRESENTATION AT 2021 CSCO ANNUAL MEETING
Regulatory Filings
2021-09-17 English
VOLUNTARY ANNOUNCEMENT - RESEARCH RESULTS ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2021
Regulatory Filings
2021-09-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Regulatory Filings
2021-09-06 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021
Regulatory Filings
2021-08-27 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Regulatory Filings
2021-08-27 English
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Regulatory Filings
2021-08-27 English
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE COLLABORATION WITH CSPC IN RELATION TO THE DEVELOPMENT AND COMMERCIALIZATION OF KN026 IN MAINLAND CHINA
Regulatory Filings
2021-08-23 English
DATE OF BOARD MEETING
Regulatory Filings
2021-08-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Regulatory Filings
2021-08-05 English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS AND E-POSTERS OF RESEARCH UPDATES ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2021
Regulatory Filings
2021-07-26 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021
Regulatory Filings
2021-07-06 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 11, 2021
Regulatory Filings
2021-06-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021
Regulatory Filings
2021-06-03 English
CONNECTED TRANSACTION ANNOUNCEMENT - TECHNOLOGY DEVELOPMENT COLLABORATION WITH SUZHOU ALPHAMAB ON JSKN003 PROJECT AND KN062 COVID-19 ANTIBODY PROJECT
Regulatory Filings
2021-05-26 English
Next Day Disclosure Return
Regulatory Filings
2021-05-26 English
2020 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Regulatory Filings
2021-05-20 English
VOLUNTARY ANNOUNCEMENT - RESEARCH RESULTS ON KN046 AND KN026 FOR PRESENTATION AT 2021 ASCO ANNUAL MEETING
Regulatory Filings
2021-05-20 English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS AND E-POSTERS OF RESEARCH UPDATES ON KN046 AND KN026 FOR PRESENTATION AT 2021 ASCO ANNUAL MEETING
Regulatory Filings
2021-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Regulatory Filings
2021-05-07 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2021-04-27 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 11, 2021
Regulatory Filings
2021-04-27 English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES&#x3b; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS&#x3b; (3) PROPOSED RE-APPOINTMENT OF AUDITORS&#x3b; AND
Regulatory Filings
2021-04-27 English
2020 Annual Report
Regulatory Filings
2021-04-27 English
GRANT OF SHARE OPTIONS
Regulatory Filings
2021-04-23 English
VOLUNTARY ANNOUNCEMENT - PRELIMINARY SAFETY TOLERABILITY AND EFFICACY RESULTS OF KN046 IN COMBINATION WITH NAB-PACLITAXEL IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER RELEASED FOR E-POSTE
Regulatory Filings
2021-04-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
Regulatory Filings
2021-04-09 English
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF MEDICAL OFFICER AND CHIEF FINANCIAL OFFICER
Regulatory Filings
2021-03-30 English
ADOPTION OF THE RESTRICTED SHARE AWARD SCHEME
Regulatory Filings
2021-03-23 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020
Regulatory Filings
2021-03-23 English
DATE OF BOARD MEETING
Regulatory Filings
2021-03-11 English
VOLUNTARY ANNOUNCEMENT - IND APPROVAL RECEIVED FOR A PHASE II CLINICAL TRIAL OF KN046 IN THE U.S.
Regulatory Filings
2021-03-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Regulatory Filings
2021-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Regulatory Filings
2021-02-04 English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON CLINICAL DATA FROM PHASE II CLINICAL STUDY OF KN046 IN PATIENTS WITH ADVANCED NSCLC AND PRELIMINARY RESULTS OF KN046 IN PATIENTS WITH RARE THORACIC TUMORS FOR PRE
Regulatory Filings
2021-01-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
Regulatory Filings
2021-01-07 English